Saliva-based Detection of CD44

计划入组 85 人 · 首次发布于 2017 年 5 月 11 日

Safety and Efficacy of EXO-CD24 in Preventing Clinical Deterioration in Patients With Mild-Moderate ARDS

计划入组 90 人 · 首次发布于 2023 年 7 月 17 日

Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection

计划入组 35 人 · 首次发布于 2021 年 2 月 10 日

EXO-CD24

CD44-3MUT

CD274 targeting antisense oligonucleotide

Immune-Based AML Subgroups Reveal Prognostic and Therapeutic Implications

Enhanced CAR-NK Cell Therapy Shows Superior Tumor Control Through Novel Costimulatory Design

Anti-PD-1 Immunotherapy Shows Superior Outcomes in Gastric Cancer Patients with Chronic Hepatitis B